This statistic shows AstraZeneca 's research & development expenditure as a percentage of its total revenue from 2006 to 2019 . In 2019 , the company invested around 26 percent of its revenue into research and development . AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide . The multinational company is headquartered in London , UK . AstraZeneca is focused on products for following major disease areas : cancer , cardiovascular , gastrointestinal , infection , neuroscience , respiratory and inflammation .
